Antidepressants - SSRIs and SNRIs: Nursing pharmacology

Last updated: January 26, 2022

Antidepressants - SSRIs and SNRIs: Nursing pharmacology

Watch later

Watch later

Cholinomimetics: Direct agonists
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Osteoporosis: Nursing
Osteomyelitis: Nursing
Paget disease of bone: Nursing
Cerebral palsy: Nursing
Down syndrome (Trisomy 21)
Encephalitis: Nursing
Headaches: Pathology review
Meningitis: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Erysipelas and cellulitis: Nursing
Antibiotics - Penicillins: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Cutaneous fungal infections: Nursing
Antibiotics - Cephalosporins: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antivirals for influenza: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Antivirals for hepatitis B and C: Nursing pharmacology
Antibiotics - Fluoroquinolones: Nursing pharmacology
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Glaucoma: Nursing process (ADPIE)
Antidepressants - SSRIs and SNRIs: Nursing pharmacology
Gout: Nursing process (ADPIE)
Antiretrovirals for HIV/AIDS - CCR5 antagonists, fusion inhibitors, and attachment inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Integrase strand transfer inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - NRTIs and NNRTIs: Nursing pharmacology
Cataracts: Nursing
Detached retina: Nursing
Macular degeneration: Nursing
Meniere disease: Nursing
Growth and development - Infant: Nursing
Otitis media: Nursing
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Diabetes mellitus (DM): Nursing process (ADPIE)
Anatomy and physiology of the eye
Physical assessment - Eyes: Nursing
Conjunctivitis: Nursing process (ADPIE)
Eye conditions: Inflammation, infections and trauma: Pathology review
Anatomy of the eye
Pediatric psychosocial needs during illness and hospitalization: Nursing
Hearing impairment and otosclerosis: Nursing
Growth and development theories: Nursing
Growth and development - Preschool-age: Nursing
Growth and development - Toddler: Nursing
Growth and development - School-age: Nursing
Growth and development - Adolescent: Nursing
Antibiotics - Carbapenems and monobactams: Nursing pharmacology
Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology
Antibiotics - Beta lactam and beta lactamase inhibitor combinations: Nursing pharmacology
Antibiotics - Aminoglycosides: Nursing pharmacology
Medications for respiratory syncytial virus (RSV): Nursing pharmacology
Mycobacterium tuberculosis (Tuberculosis)
Hypersensitivity reactions - Type II: Nursing
Lyme disease: Nursing process (ADPIE)
Systemic lupus erythematosus (SLE): Nursing
Preoperative care: Nursing
Postoperative care: Nursing
Chest tube care: Nursing
Analgesics for obstetrics: Nursing pharmacology
Analgesics: Nursing pharmacology
Acne: Nursing
Burn injury: Nursing
Impetigo: Nursing
Insect stings and bites: Nursing
Psoriasis: Nursing
Herpes zoster: Nursing
Urticaria: Nursing
Pressure injury: Nursing process (ADPIE)
Cholinergic therapy (GU): Nursing pharmacology
Physical assessment - Skin, hair, and nails: Nursing
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Narcolepsy (NORD)
Autism spectrum disorder (ASD): Nursing
Insomnia
Hemorrhagic stroke - Intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH): Nursing
Body fluid compartments
Anemia - Macrocytic: Nursing
Anemia - Iron-deficiency: Nursing
Vitamin D
Vitamin B12 deficiency
Role of Vitamin K in coagulation
Folate (Vitamin B9) deficiency
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type IV: Nursing
Immune response - Adaptive: Nursing
Immune response - Innate: Nursing
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS): Nursing
Antiglaucoma medications: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Antihistamines: Nursing pharmacology
Antacids: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Physiology of pain: Nursing

Notes

ANTIDEPRESSANTS: SSRIs, SNRIs
DRUG NAME
fluoxetine (Prozac), fluvoxamine (Luvox), sertraline (Zoloft), paroxetine (Paxil, Pexeva), citalopram (Celexa), escitalopram (Lexapro)
duloxetine (Cymbalta), venlafaxine (Effexor), desvenlafaxine (Pristiq), levomilnacipran (Fetzima)
CLASS
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin-norepinephrine reuptake inhibitors (SNRIs)
MECHANISM OF ACTION
Inhibit serotonin reuptake, increasing its concentration in the synaptic cleft
Inhibit serotonin and norepinephrine reuptake, increasing their concentration in the synaptic cleft
INDICATIONS
  • Major depressive disorder
  • Anxiety disorders (obsessive-compulsive disorder, posttraumatic stress disorder, panic disorder, phobias)
  • Phobias
  • Major depressive disorder
  • Generalized anxiety disorder
  • Neuropathic pain
ROUTE(S) OF ADMINISTRATION
PO
SIDE EFFECTS
  • Anxiety
  • Nervousness
  • Agitation
  • Dizziness
  • Drowsiness
  • Insomnia
  • Loss of appetite
  • Nausea
  • Vomiting
  • Diarrhea
  • Sexual dysfunction
  • Headache
  • Sweating
  • Hyponatremia
  • Dry mouth
  • Bruxism
  • Serotonin syndrome
  • Boxed warning: suicidal thinking in children, adolescents, and young adults
  • SNRIs: hypertension, tachycardia, closed-angle glaucoma, urinary retention
CONTRAINDICATIONS AND CAUTIONS
  • Combination with MAOIs
  • QT prolongation or myocardial infarction
  • Pregnancy
  • Renal or hepatic disease
  • Diabetes
  • Glaucoma
  • Severely depressed clients with suicidal thinking
NURSING CONSIDERATIONS
Assessment and monitoring: SSRIs and SNRIs
  • Baseline assessment of depressive symptoms; continue during antidepressant therapy
  • Monitor for suicidal thoughts, especially during the first few weeks
  • Baseline mental status, vital signs, weight, serum electrolytes, kidney and liver function
  • Pregnancy status

Client education: SSRIs and SNRIs
  • Therapeutic effects can take 1–3 weeks
  • Take medication exactly as prescribed
  • Report any changes in symptoms or suicidal thoughts to health care provider
  • Administer medication in the morning
  • Avoid hazardous activities with fatigue and dizziness
  • Notify healthcare provider about adverse effects
    • SNRIs: Void before taking this medication
  • Never abruptly stop medication therapy
Author: Victoria S. Recalde, MD
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Antidepressants are medications primarily used to treat major depressive disorder, which is a condition associated with a persistent feeling of sadness and loss of interest in everyday activities.

Even though the exact cause of major depressive disorder is still unknown, there's some evidence that suggests that it’s related to low levels of neurotransmitters called monoamines, which include serotonin, norepinephrine, and dopamine.

In this video, we’re going to cover two of the main classes of antidepressants: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors.

First, let’s focus on selective serotonin reuptake inhibitors, or SSRIs for short, such as fluoxetine, fluvoxamine, sertraline, paroxetine, citalopram, and escitalopram.

SSRIs are taken orally, and once absorbed into the bloodstream, they travel to the brain. Here, SSRIs inhibit the reuptake of serotonin.

As a result, free levels of serotonin within the synaptic cleft are increased right away, although the effect of SSRIs alleviating symptoms of depression are not evident for a few weeks.

Other indications for SSRIs include anxiety disorders like obsessive-compulsive disorder, or OCD; post traumatic stress disorder, or PTSD; panic disorder and phobias; as well as eating disorders like bulimia.

On the other hand, serotonin-norepinephrine reuptake inhibitors, or SNRIs, include duloxetine, venlafaxine, desvenlafaxine, and levomilnacipran.

SNRIs are also taken orally, and once they reach the brain, they inhibit the reuptake of both serotonin and norepinephrine, increasing their levels in the synaptic cleft.

Other indications for SNRIs besides major depressive disorder include generalized anxiety disorder and neuropathic pain.

Now, the brain has different types of serotonin receptors besides the ones involved in depression. Some of them mediate functions like mood, sleep, appetite, or sexual function.

So, some side effects of SSRIs and SNRIs include anxiety or nervousness, agitation, insomnia or drowsiness, loss of appetite, and sexual dysfunction.

Other side effects include headache, dizziness, sweating, and hyponatremia, as well as bruxism, dry mouth, nausea, vomiting, and diarrhea.

Additionally, SSRIs and SNRIs can also cause serotonin syndrome, which usually occurs when these medications are combined with other antidepressants that increase the level of serotonin in the brain, especially monoamine oxidase inhibitors, or MAOIs for short.

Clients that develop serotonin syndrome typically present with skin flushing, hyperthermia, agitation, muscle rigidity, seizures, and altered mental status or even coma.

Now, SNRIs also increase the levels of norepinephrine, so they can cause side effects like hypertension and tachycardia, as well as closed-angle glaucoma, and urinary retention.

Finally, an important boxed warning for all antidepressants is that they may increase the risk of suicidal thinking in children, adolescents, and young adults.

Sources

  1. "Focus on Nursing Pharmacology" LWW (2019)
  2. "Pharmacology" Elsevier Health Sciences (2014)
  3. "Mosby's 2021 Nursing Drug Reference" Mosby (2020)
  4. "Saunders Comprehensive Review for the NCLEX-RN Examination" Saunders (2016)
  5. "SSRI Antidepressant Medications" The Primary Care Companion to The Journal of Clinical Psychiatry (2001)